3 articles
HB Fuller is reviewing the sale of noncore assets after rejecting a second unsolicited bid from Ancora for its Building Adhesive Solutions business valued at up to $1.4 billion. The adhesives producer
HB Fuller CEO reports GLP-1 weight-loss drugs are reducing packaged food consumption, depressing demand for adhesives and food packaging. The trend also affects food ingredient distributors, compounde
Ancora Holdings renewed its proxy fight threat against HB Fuller over the £715 million acquisition of Advanced Medical Solutions (AMS). HB Fuller aims to expand into medical adhesives, though investor
ChemBrief